Quantum SI

About:

Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.

Website: https://www.quantum-si.com/

Twitter/X: quantum_si

Top Investors: Foresite Capital, ARK Investment Management, Glenview Capital Management, Redmile Group, 4Catalyzer

Description:

Quantum-Si is focused on revolutionizing the growing field of proteomics. The company’s suite of technologies are powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

Total Funding Amount:

$425M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Guilford, Connecticut, United States

Founded Date:

2013-01-01

Founders:

Daniel Fox, Jonathan M Rothberg

Number of Employees:

101-250

Last Funding Date:

2021-06-11

IPO Status:

Public

© 2025 bioDAO.ai